Intention and hesitancy to receive a booster dose of COVID-19 vaccine among pregnant women using a health belief model: A cross-sectional study

Author:

Al-Taie Anmar1,Yilmaz Zekiye2,Çakiroğlu Ahmet Yiğit3,Candan Gulnihal1,Bildirici Selin4

Affiliation:

1. Clinical Pharmacy Department, Faculty of Pharmacy, Istinye University, Istanbul, Türkiye

2. Clinical Pharmacy Department, Faculty of Pharmacy, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Türkiye

3. Obstetrics and Gynaecology Department, Faculty of Medicine, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Türkiye

4. Uskudar American Academy, Istanbul, Türkiye

Abstract

Objective: To examine the pattern of COVID-19 infection and vaccination, and to explore pregnant women's willingness and reluctance to accept a booster dose of the COVID-19 vaccine. Methods: This was a cross-sectional, descriptive study with a convenient sample size using a structured questionnaire among pregnant women attending the gynecology and obstetrics department at Acıbadem Mehmet Ali Aydinlar Hospital, Istanbul, Türkiye. The Health Belief Model scale was used to assess the intention and reluctance to accept a booster dose of the COVID-19 vaccine. Results: A total of 145 participants, with a mean age of (33.5±4.8) years, and a gestational age of (30.9±7.3) weeks, were enrolled in this study. 88.8% Received full doses of the Pfizer-BioNTech vaccination. 47.8% Participants suffered from vaccine adverse effects. Health Belief Model demonstrated a significant finding of perceived susceptibility (P<0.001), perceived severity of COVID-19 complications (P<0.001), and perceived benefits regarding a booster COVID-19 vaccination (P<0.001). Conclusions: Most pregnant women who received the COVID-19 immunization express a significant intention to receive a booster dose, regardless of the adverse effects experienced from the previous doses. However, a small percentage of the study sample express hesitancy about receiving the booster dose.

Publisher

Medknow

Reference32 articles.

1. Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low income and middle-income countries: A modelling study;Roberton;Lancet Glob Health,2020

2. Tixagevimab and Cilgavimab: Can we see more recommendations for monoclonal antibodies beyond COVID-19 vaccination;Anmar;Disaster Med Public Health Prep,2022

3. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis;Allotey;BMJ,2020

4. The association of COVID-19 infection in pregnancy with preterm birth: A retrospective cohort study in California;Karasek;Lancet Reg Health Am,2021

5. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: The INTERCOVID multinational cohort study;Villar;JAMA Pediatr,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3